This study discovered that a beneficial bacterium called P. melaninogenica bolsters the immune defenses in the lung against infection with pneumococcal pneumonia. Pneumonia is the leading cause of death in children under 5, so this research is important to understand why some are more predisposed to lung infection than others, and why antibiotics may not be effective. Senior author Dr. Sarah E. Clark is funded by the American Lung Association Innovation Award.
Join over 700,000 people who receive the latest news about lung health, including research, lung disease, air quality, quitting tobacco, inspiring stories and more!
Thank you! You will now receive email updates from the American Lung Association.